Mesoblast (NASDAQ:MESO; ASX:MSB) appointed William Burns, a director, as vice chairman.
In this role, Mr. Burns, a former CEO of Roche Pharmaceuticals from 2001 to 2009, will focus his considerable pharmaceutical industry expertise on activities relating to execution of major strategic partnerships and corporate transactions.
“As the company has multiple advanced product candidates approaching commercialization, we are very pleased that Bill Burns has agreed to expand his role on the board to focus on delivery of optimal transactional outcomes,” vice chairman, Brian Jamieson, said in a statement.
